Annovis Bio Inc. (ANVS) is priced at $111.00 after the most recent trading session. At the very opening of the session, the stock price was $103.24 and reached a high price of $111.85, prior to closing the session it reached the value of $101.18. The stock touched a low price of $100.18.
Recently in News on July 20, 2021, Annovis Bio Reports Positive Safety Data from its Phase 2 Alzheimer’s Study. Safety and tolerability data for Cohort 2 of the Discover Study reviewed by Data Safety Monitoring Board, allowing the study to proceed with the final cohort. You can read further details here
Annovis Bio Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $125.95 on 07/09/21, with the lowest value was $7.42 for the same time period, recorded on 01/04/21.
Annovis Bio Inc. (ANVS) full year performance was 1581.82%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Annovis Bio Inc. shares are logging -11.87% during the 52-week period from high price, and 2581.16% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $4.14 and $125.95.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 550857 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Annovis Bio Inc. (ANVS) recorded performance in the market was 1372.15%, having the revenues showcasing 408.71% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 852.48M, as it employees total of 2 workers.
Specialists analysis on Annovis Bio Inc. (ANVS)
During the last month, 0 analysts gave the Annovis Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 50.82, with a change in the price was noted +85.43. In a similar fashion, Annovis Bio Inc. posted a movement of +334.10% for the period of last 100 days, recording 977,650 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ANVS is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Annovis Bio Inc. (ANVS)
Raw Stochastic average of Annovis Bio Inc. in the period of last 50 days is set at 85.56%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 70.15%. In the last 20 days, the company’s Stochastic %K was 56.63% and its Stochastic %D was recorded 53.38%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 1372.15%. Additionally, trading for the stock in the period of the last six months notably improved by 1012.22%, alongside a boost of 1581.82% for the period of the last 12 months. The shares increased approximately by -3.29% in the 7-day charts and went down by 15.50% in the period of the last 30 days. Common stock shares were driven by 408.71% during last recorded quarter.